Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-19-001034
Date:2019-02-13
Issuer: SAGE THERAPEUTICS, INC. (SAGE)
Original Submission Date:

Reporting Person:

ROBICHAUD ALBERT
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 157.63 2019-02-13 deemed execution date A 19,000 (a) 2029-02-13 common stock 19,000 $157.63 19,000 direct
Footnotes
IDfootnote
f1 the securities awarded on february 13, 2019 were in the form of stock options issued pursuant to the sage therapeutics, inc. 2014 stock option and incentive plan. options to purchase 4,750 shares of common stock shall vest on the one year anniversary of february 13, 2019, with 14,250 shares vesting in 36 equal monthly installments thereafter.
WhaleWisdom Logo

Elevate your investments